FindTrial
Sign In

Inhalational anesthetic requirements during hepatocellular carcinoma operation

Inhalational anesthetic requirements during hepatocellular carcinoma operation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001375
Enrollment
55
Registered
2015-02-05
Start date
2014-11-04
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: the age from 20 to 65 patients with hepatocellular carcinoma surgery in Samsung medical center

Exclusion criteria

Exclusion criteria: medications known to affect minimal alveolar concentration(Ex. opioid, sedative) during intraoperative study time using opioid,continous inotropics

Design outcomes

Primary

MeasureTime frame
end tidal concentration of inhalational anesthetics—

Secondary

MeasureTime frame
the related factor for Inhalational anesthetic requirements—

Countries

Korea, Republic of

Contacts

Public ContactMihye Park

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026